Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
US6984720 | NA | Human CTLA-4 antibodies |
Mar, 2025
(1 year, 6 months from now) |
Ingredients: IPIILIMUMAB
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic